Identification and Semi -Quantification of ER/PR Proteins Expression



Status:Completed
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:20 - 80
Updated:4/21/2016
Start Date:May 2013
End Date:December 2014

Use our guide to learn which trials are right for you!

Identification and Semi -Quantification of ER/PR Proteins Expression Status in Formalin Fixed, Paraffin-embedded Normal and Neoplastic Tissue

The purpose of the study is the identification and quantification of proteins expression
level in breast cancer tissues.

The imaging system is intended for diagnostic use as an aid to the pathologist in the
detection, counting and classifying ER/PR IHC stained samples.

The anti ER/PR Kit is a semi-quantitative immunohistochemical (IHC) assay to identify the
progesterone (PR) and estrogen (ER) expressions in formalin-fixed, paraffin-embedded human
breast cancer tissue specimens. Results from the ER/PR test is indicated as an aid in the
assessment of the hormones status of breast cancer patients. While the ER/PR kit provides
the antibodies that offer direct visualization and semi-quantification of the protein
expression through a brightfield microscope, the GenASIs GoPath system is designed to
complement the routine workflow of the pathologist in the review of immunohistochemically
stained histologic slides.

Inclusion Criteria:

- Women having breast cancer

Exclusion Criteria:

- others
We found this trial at
1
site
Temple, Texas 76508
?
mi
from
Temple, TX
Click here to add this to my saved trials